Amdocs Limited (NASDAQ:DOX – Get Free Report) has been assigned a consensus rating of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $86.6667.
DOX has been the topic of several recent analyst reports. Cfra cut shares of Amdocs to a “sell” rating in a research report on Thursday, May 14th. KeyCorp started coverage on Amdocs in a report on Monday, June 29th. They set a “sector weight” rating on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Sunday, July 5th. Finally, Stifel Nicolaus decreased their target price on Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research report on Thursday, May 14th.
Check Out Our Latest Research Report on DOX
Institutional Inflows and Outflows
Amdocs Stock Down 3.2%
Shares of DOX stock traded down $1.80 on Thursday, hitting $55.02. The stock had a trading volume of 58,839 shares, compared to its average volume of 1,298,593. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.98 and a quick ratio of 0.98. The business has a 50 day moving average of $55.20 and a 200 day moving average of $64.49. Amdocs has a 12-month low of $49.74 and a 12-month high of $90.29. The stock has a market cap of $5.94 billion, a price-to-earnings ratio of 11.00, a price-to-earnings-growth ratio of 0.95 and a beta of 0.41.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business had revenue of $1.17 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the previous year, the company earned $1.78 earnings per share. The firm’s revenue for the quarter was up 3.9% compared to the same quarter last year. As a group, analysts expect that Amdocs will post 6.56 EPS for the current year.
Amdocs Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Tuesday, June 30th. Amdocs’s dividend payout ratio (DPR) is 45.60%.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Stories
- Five stocks we like better than Amdocs
- 2 Unique Space ETFs That Could Upend the Industry
- Corning Stock Crashes on Earnings, But the Sell-Off Looks Overdone
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
- Mining For Megawatts: AMD’s Billion-Dollar Grid Grab
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
